The inclusion of Thomas Riga in the Chimerix leadership team...
The inclusion of Thomas Riga in the Chimerix leadership team is expected to boost the company’s operations given his extensive experience in oncology commercialization and corporate business development, especially as the company gears towards commercializing its clinical-stage development program, ONC201.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000002586ae848ab583.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment